- Hemoglobin Variability Associated with Erythropoiesis Stimulating Agents
-
Bae EH
- KMID: 2307149
- Korean J Nephrol.
- 2011 Jan;30(1):1-3.
No abstract available. -
- CITED
-
- Close
- SHARE
-
- Close
- Anemia and nutrition in end stage renal disease patient
-
Oak CY, Kim NH
- KMID: 2193049
- J Korean Med Assoc.
- 2013 Jul;56(7):592-599.
- doi: 10.5124/jkma.2013.56.7.592
Anemia and malnutrition are common complications of end-stage renal disease. They increase the morbidity and mortality of end-stage renal disease patients and affect their quality of life. However, the mechanisms... -
- CITED
-
- Close
- SHARE
-
- Close
- New Oral Agent for Treatment of Anemia in Patient with Chronic Kidney Disease: Prolyl Hydroxylase Inhibitor
-
Na K
- KMID: 2438025
- Korean J Med.
- 2019 Feb;94(1):11-16.
- doi: 10.3904/kjm.2019.94.1.11
Hypoxia inducible factor (HIF)-stabilizers are being developed for the renal anemia treatment. This small molecules inhibit prolyl hydroxylase domain (PHD)-containing enzymes, causing HIF activation instead of degradation under the state... -
- CITED
-
- Close
- SHARE
-
- Close
- Hemoglobin Variability Associated with Different Erythropoiesis Stimulating Agents in Hemodialysis Patients
-
Park SK, Hwang KS, Park JS, Lee CH, Kang CM, Kim GH
- KMID: 2307154
- Korean J Nephrol.
- 2011 Jan;30(1):41-47.
PURPOSE: This study was undertaken to examine whether differences exist in the hemoglobin variability according to the types of erythropoiesis stimulating agent (ESA) in hemodialysis (HD) patients. METHODS: Clinical data were... -
- CITED
-
- Close
- SHARE
-
- Close
- The Global Developments in Transfusion Replacements and Patient Blood Management
-
Yang H, Kim YW
- KMID: 2391227
- Korean J Blood Transfus.
- 2017 Aug;28(2):103-112.
- doi: 10.17945/kjbt.2017.28.2.103
Blood transfusions were once believed to the most potent and cost-effective method of improving patients' survival outcomes, but accumulating evidence over the past thirty years strongly suggests allogeneic transfusions as... -
- CITED
-
- Close
- SHARE
-
- Close
- Idiopathic erythrocytosis in a patient on chronic hemodialysis
-
Lee DH, Min JH, Bae SB, Gil HW, Yang JO, Lee EY, Hong SY
- KMID: 2381516
- Kidney Res Clin Pract.
- 2015 Mar;34(1):60-63.
- doi: 10.1016/j.krcp.2014.09.004
A 78-year-old man on hemodialysis presented to our hospital with erythrocytosis. He had started hemodialysis 4 years previously, with a hemoglobin level of 9.8 g/dL, and was administered erythropoiesis stimulating... -
- CITED
-
- Close
- SHARE
-
- Close
- Frequency and Pattern of Hemoglobin Cycling in Korean Hemodialysis Patients Treated with Erythropoiesis Stimulating Agent
-
Hwang DS, Chung HC, Lee JH, Hwang YT, Seo JM, Lee JS, Park J
- KMID: 2079747
- Korean J Nephrol.
- 2007 Jul;26(4):427-434.
PURPOSE: It is frequently observed that the level of hemoglobin (Hb) widely fluctuates during treatment of erythropoiesis stimulating agents (ESAs) in hemodialysis (HD) patients, known as Hb cycling. The purpose... -
- CITED
-
- Close
- SHARE
-
- Close
- Treatment of renal anemia: Erythropoiesis stimulating agents and beyond
-
Biggar P, Kim GH
- KMID: 2416090
- Kidney Res Clin Pract.
- 2017 Sep;36(3):209-223.
- doi: 10.23876/j.krcp.2017.36.3.209
Anemia, complicating the course of chronic kidney disease, is a significant parameter, whether interpreted as subjective impairment or an objective prognostic marker. Renal anemia is predominantly due to relative erythropoietin... -
- CITED
-
- Close
- SHARE
-
- Close
- The Prevalence and Management of Anemia in Chronic Kidney Disease Patients: Result from the KoreaN Cohort Study for Outcomes in Patients With Chronic Kidney Disease (KNOW-CKD)
-
Ryu SR, Park SK, Jung JY, Kim YH, Oh YK, Yoo TH, Sung S
- KMID: 2364168
- J Korean Med Sci.
- 2017 Feb;32(2):249-256.
- doi: 10.3346/jkms.2017.32.2.249
Anemia is a common and significant complication of chronic kidney disease (CKD). However, its prevalence and current management status has not been studied thoroughly in Korea. We examined the prevalence... -
- CITED
-
- Close
- SHARE
-
- Close
- Comparison of Once-Biweekly Administration of Epoetin-alpha with Darbepoetin-alpha in Chronic Kidney Disease Patients Not Receiving Dialysis
-
Kim SY, Choi HJ, Choi HJ, Lee CE, Yun SU, Park JH, Lee JH, Song JO, Jo YI
- KMID: 2252974
- Korean J Nephrol.
- 2010 Sep;29(5):562-569.
PURPOSE: It is very important to correct renal anemia by erythropoiesis stimulating agents (ESA) because anemia is associated with poor outcomes in chronic kidney disease (CKD) patients. We investigated whether... -
- CITED
-
- Close
- SHARE
-
- Close
- Erythropoiesis-stimulating Agents and Anemia in Patients with Non-dialytic Chronic Kidney Disease
-
Kim SM, Kim KM, Kwon SK, Kim HY
- KMID: 2359992
- J Korean Med Sci.
- 2016 Jan;31(1):55-60.
- doi: 10.3346/jkms.2016.31.1.55
Anemia is common in patients with advanced chronic kidney disease (CKD). Though erythropoiesis-stimulating agents (ESAs) have been strongly endorsed in guidelines, it is of particular financial interest. Recently, the reimbursement... -
- CITED
-
- Close
- SHARE
-
- Close
- Comparison of the Efficacies of Parenteral Iron Sucrose and Oral Iron Sulfate for Anemic Patients with Inflammatory Bowel Disease in Korea
-
Han YM, Yoon H, Shin CM, Koh SJ, Im JP, Kim BG, Kim JS, Jung HC
- KMID: 2412044
- Gut Liver.
- 2016 Jul;10(4):562-568.
- doi: 10.5009/gnl15373
BACKGROUND/AIMS: The optimal route for iron administration in anemic patients with inflammatory bowel disease (IBD) has not been determined. The aim of this study was to compare the efficacies of... -
- CITED
-
- Close
- SHARE
-
- Close
- Effect of anemia correction on left ventricular structure and filling pressure in anemic patients without overt heart disease
-
Cho IJ, Mun YC, Kwon KH, Shin GJ
- KMID: 2070108
- Korean J Intern Med.
- 2014 Jul;29(4):445-453.
BACKGROUND/AIMS: There are few data on the effects of low hemoglobin levels on the left ventricle (LV) in patients without heart disease. The objective of this study was to document... -
- CITED
-
- Close
- SHARE
-
- Close
- Current Status of Dialysis Therapy in Korea
-
Jin DC
- KMID: 1776582
- Korean J Intern Med.
- 2011 Jun;26(2):123-131.
- doi: 10.3904/kjim.2011.26.2.123
The number of patients with end-stage renal disease (ESRD) is rising very rapidly as the number of elderly and patients with diabetes increases in Korea. ESRD Registry Committee of the... -
- CITED
-
- Close
- SHARE
-
- Close
- Erythropoietin Improves Long-Term Outcomes in Patients with Acute Kidney Injury after Coronary Artery Bypass Grafting
-
Oh SW, Chin HJ, Chae DW, Na KY
- KMID: 1372792
- J Korean Med Sci.
- 2012 May;27(5):506-511.
- doi: 10.3346/jkms.2012.27.5.506
Previous studies reported the beneficial effect of erythropoietin (EPO) in acute injuries. We followed patients with and without acute kidney injury (AKI) after coronary artery bypass grafting (CABG) and evaluated... -
- CITED
-
- Close
- SHARE
-
- Close
- Improvement in Erythropoieis-stimulating Agent-induced Pure Red-cell Aplasia by Introduction of Darbepoetin-alpha When the Anti-erythropoietin Antibody Titer Declines Spontaneously
-
Lee H, Yang J, Kim H, Kwon JW, Oh KH, Joo KW, Kim YS, Ahn C, Han JS, Kim S
- KMID: 1779243
- J Korean Med Sci.
- 2010 Nov;25(11):1676-1679.
- doi: 10.3346/jkms.2010.25.11.1676
Anti-erythropoietin antibodies usually cross-react with all kinds of recombinant erythropoietins; therefore, erythropoiesis-stimulating agent (ESA)-induced pure red-cell aplasia (PRCA) is not rescued by different ESAs. Here, we present a case of... -
- CITED
-
- Close
- SHARE
-
- Close
